Home - Products - Others - Other Targets - Hepcidin-22 (human) trifluoroacetate salt

Hepcidin-22 (human) trifluoroacetate salt

CAS No. 342790-22-1

Hepcidin-22 (human) trifluoroacetate salt( ——— )

Catalog No. M41736 CAS No. 342790-22-1

Hepcidin-22 (human) is an inactive degradation product of hepcidin-25 that is present in the urine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Hepcidin-22 (human) trifluoroacetate salt
  • Note
    Research use only, not for human use.
  • Brief Description
    Hepcidin-22 (human) is an inactive degradation product of hepcidin-25 that is present in the urine.
  • Description
    Hepcidin-22 (human) is an inactive degradation product of hepcidin-25 that is present in the urine.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    342790-22-1
  • Formula Weight
    2436.08
  • Molecular Formula
    C99H151N29O25S9
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kroot JJ, et al. Hepcidin in human iron disorders: diagnostic implications. Clin Chem. 2011 Dec;57(12):1650-69.?
molnova catalog
related products
  • H-Ser-Ser-Arg-Leu-Al...

    H-Ser-Ser-Arg-Leu-Ala-EDANS

  • Kanshone H

    Kanshone H is a natural product for research related to life sciences.

  • Eliglustat hemitartr...

    Eliglustat Hemitartrate, with an IC50 of 24 nM, is a specific, potent, oral active glucocerebral glycosidase inhibitor.Eliglustat tartrate shows good potency with an IC50 of 24 nM and specificity against the target enzyme.A novel inhibitor of glucosylceramide synthase (Genz-112638) and assessed its activity in a murine model of Gaucher disease (D409V/null).?Biochemical characterization of Genz-112638 showed good potency (IC(50) approximately 24nM) and specificity against the target enzyme.?